secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0000950170-25-104054
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q2 revenue up 15% to $31.4M; raises FY2025 guidance to $122-126M
-------------------------------------------------------------------------------

- Net revenue $31.4M (+15% YoY); Tablo console revenue up 25%; recurring revenue $22.5M (+11%).
- Non-GAAP gross margin 38.4% (+110bps); operating expenses down 29% YoY; net loss $18.5M vs $34.5M.
- Raised 2025 revenue guidance to $122-126M from $115-125M; expects <$50M cash use vs >$100M in 2024.
- New enterprise agreement with large national health system; Tablo now in >900 U.S. acute/sub-acute sites.
- Cash $187.4M at June 30; H1 cash burn reduced ~60% vs prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017025104054/0000950170-25-104054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017025104054/om-20250806.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-104054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer